Interview | Prof. Dr. Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens (MPUSP)

"Basic research is the basis for innovation"





For her groundbreaking work at the molecular mechanisms of a bacterial immune system, called CRISPR/Cas9, and its repurpose into a tool for genome editing, Prof. Dr. Emmanuelle Charpentier won the nobel prize in chemistry in 2020, together with Jennifer Doudna from the University of California, Berkeley, USA.  

In 2018 she founded the independent Max Planck Unit for the Science of Pathogens (MPUSP) to strengthen fundamental research on pathogens causing diseases in humans.  

In the Brain City interview, she tells us about her goals, her current research, advantages of Berlin as a science location and her love of sports and culture. 

Read the interview at